People channel feed

BioN­Tech chief Ugur Sahin gains star sta­tus in the ex­clu­sive Cov­il­lion­aire club

5 years ago
R&D

Lau­ra Shawver is about to join a line­up of biotech CEOs en­joy­ing overnight for­tunes, cour­tesy of the biotech IPO boom

5 years ago
Financing

A top can­cer R&D ex­ec at Genen­tech joins the ex­o­dus, jump­ing to a mar­quee Chi­na biotech as the new on­col­o­gy chief, deal­mak­er

5 years ago

Not so fast, Mr Pres­i­dent: Trump's plan for low­er­ing pre­scrip­tion drug prices hits a road­block, as Cana­da bans bulk drug ex­ports

5 years ago
Pharma

Plot thick­ens around Leg­end Biotech, Gen­Script with founder Frank Zhang's ar­rest

5 years ago
China

Vivek Ra­maswamy’s Meta­vant hits a brick wall, aban­don­ing a lead pro­gram for di­a­betes. And there’s noth­ing vis­i­ble left to see here

5 years ago
R&D

For­mer MiMedx CEO and COO are con­vict­ed on fraud, con­spir­a­cy charges

5 years ago

Amid scruti­ny of ex­ec stock sales, SEC chair­man echoes calls for 'cool­ing-off pe­ri­od' in trad­ing plans

5 years ago
FDA+

Phar­ma lob­by­ist and long­time Biden loy­al­ist Steve Ric­chet­ti joins the in­ner cir­cle head­ed to the White House as drug pric­ing re­mains a hot top­ic

5 years ago
Pharma

Retrophin no more: Shkre­li's lega­cy dis­ap­pears as for­mer com­pa­ny be­comes Tra­vere Ther­a­peu­tics

5 years ago
Pharma

Fa­heem Has­nain is go­ing back to run­ning a biotech start­up. And he has his work cut out for him

5 years ago
R&D

A phar­ma R&D chief jumps to a bud­ding new start­up fac­to­ry — and this time he’s found 'some­thing com­plete­ly dif­fer­ent’

5 years ago
Startups

As the cur­tain clos­es on the Trump pres­i­den­cy, biotech wres­tles with its fu­ture in a di­vid­ed Amer­i­ca

5 years ago
In Focus

As Pfiz­er's stock surged Mon­day, Al­bert Bourla net­ted $5.6M in stock sales

5 years ago
Coronavirus

Vivek Ra­maswamy eyes an I/O vant with up to $2B li­cens­ing deal

5 years ago
Deals

'We're not a van­t': Ax­o­vant seeks to for­get the past as the com­pa­ny re­brands to Sio Gene Ther­a­pies

5 years ago
Cell/Gene Tx

Leg­end Biotech has a new chair­woman and per­ma­nent CEO. But where is Frank Zhang?

5 years ago
Cell/Gene Tx

Two years af­ter a re­buffed ac­tivist at­tack, Alex Den­ner fi­nal­ly gets his seat on Iron­wood's board

5 years ago

Pre­vail and Alec­tor both claim vic­to­ry in ar­bi­tra­tion over sci­en­tist-CEO, telling di­ver­gent tales of con­fi­den­tial hear­ings

5 years ago
Pharma

San­thera ax­es half its em­ploy­ees and sees CMO de­part af­ter PhI­II DMD fail

5 years ago
R&D

Sean Bo­hen just wrote the hand­book on how to make a quick for­tune in biotech

5 years ago
Financing
Bioregnum

Bel­licum slash­es 79% of staffers af­ter ear­ly da­ta quash hope around next-gen CAR-T

5 years ago
Cell/Gene Tx

George Golumbes­ki and Fa­heem Has­nain team up with Ver­tex Ven­tures HC in man­ag­ing $320M of biotech cash

5 years ago
Financing

Bay­er fol­lows R&D deal spree by raid­ing Roche's can­cer group for its new re­search chief

5 years ago
R&D
First page Previous page 63646566676869 Next page Last page
A service from the Financial Times